Market revenue in 2023 | USD 28.6 million |
Market revenue in 2030 | USD 45.4 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 90.21% in 2023. Horizon Databook has segmented the Sweden implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
The healthcare system in Sweden spends more on healthcare than any other European country, i.e., around 11% of the total GDP was spent in 2022. More than 10,000 people in Sweden suffer from SCA every year.
However, the survival rate in the country is much higher compared to other European countries, which doubled over the past 20 years. This can be attributed to the initiatives undertaken by the Government of Sweden in the prevention methods for SCA.
Furthermore, as per a study published in February 2020, in Scandinavian Cardiovascular Journal, the mean age of ICD implant in population was determined at 53 ± 15, with a predominant proportion of ICD implantations recorded in males.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into Sweden implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account